ProKidney Corp (NASDAQ: PROK) is 92.89% higher on its value in year-to-date trading and has touched a low of $0.46 and a high of $4.92 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PROK stock was last observed hovering at around $3.73 in the last trading session, with the day’s gains setting it 0.61%.
Currently trading at $4.34, the stock is 306.88% and 379.23% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 209.37 million and changing 16.35% at the moment leaves the stock 216.17% off its SMA200. PROK registered 156.80% gain for a year compared to 6-month loss of 133.33%. The firm has a 50-day simple moving average (SMA 50) of $0.90562 and a 200-day simple moving average (SMA200) of $1.372685.
The stock witnessed a 343.94% gain in the last 1 month and extending the period to 3 months gives it a 632.98%, and is 667.87% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 99.28% over the week and 37.11% over the month.
ProKidney Corp (PROK) has around 204 employees, a market worth around $1.27B and $0.31M in sales. Profit margin for the company is -22362.09%. Distance from 52-week low is 842.86% and -11.79% from its 52-week high.
The EPS is expected to grow by 21.23% this year
100.0 institutions hold shares in ProKidney Corp (PROK), with institutional investors hold 59.55% of the company’s shares. The shares outstanding are 129.54M, and float is at 94.19M with Short Float at 17.84%. Institutions hold 41.66% of the Float.
The top institutional shareholder in the company is MORGAN STANLEY with over 14.45 million shares valued at $35.54 million. The investor’s holdings represent 19.034 of the PROK Shares outstanding. As of 2024-06-30, the second largest holder is SUVRETTA CAPITAL MANAGEMENT, LLC with 9.34 million shares valued at $22.98 million to account for 12.306 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 3.98 million shares representing 5.237 and valued at over $9.78 million, while BLACKROCK INC. holds 4.8167 of the shares totaling 3.66 million with a market value of $8.99 million.
ProKidney Corp (PROK) Insider Activity
The most recent transaction is an insider sale by Weber Darin J., the company’s Chief Regulatory Officer. SEC filings show that Weber Darin J. sold 103,480 shares of the company’s common stock on Jul 08 ’25 at a price of $3.02 per share for a total of $0.31 million. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Apr 22 ’25, Control Empresarial de Capital (Add’l Rep. Persons-see Ex.99-1) acquired 387,393 shares at an average price of $0.71 for $0.28 million. The insider now directly holds 73,842,723 shares of ProKidney Corp (PROK).
